Among patients who took at least two doses of medication, GLP-1 receptor agonists were associated with a significantly lower ...

New study questions benefits of GLP-1 drugs for weight loss, finding high costs with little long-term health benefit. Read ...

For GLP-1 treatment in particular, employers “need to make sure the coverage is married with a patient engagement program, ...

Less than a week after the U.S. Food & Drug Administration (FDA) determined that the shortage of the tirzepatide injection, a glucagon-like peptide ...

An analysis of over 400,000 patients with T1D revealed a rise in prescribing for glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter 2 inhibitors over the past decade.

The 62-year-old administrative law judge has Type 1 diabetes and needs the medication to live. (Alltucker, 10/24) KFF Health News: PBM Math: Big Chains Are Paid $23.55 To Fill A Blood Pressure Rx.

Demand for GLP-1s has not slowed, and employers still have not cracked the code on the perfect solution for medications that represent a growing portion of spend. | LAS VEGAS—Demand for GLP-1s has not ...

While the regulator has not approved their use in type 1 diabetes, off-label prescribing for GLP-1 receptor agonists has ...

The brain has GLP -1 receptors in abundance and, though very little drug seems to be able to cross the blood-brain barrier ...

Expanding access to cutting-edge diabetes and weight-loss drugs like Ozempic and Zepbound could prevent more than 42 ...

New guidelines for stroke prevention from the American Stroke Association emphasize the benefits of GLP-1 drugs, a balanced ...

Cedars-Sinai experts believe the study's findings can play a crucial role in developing healthcare policies that promote ...